Saturday, August 22, 2026
ExploreSearch
Via News
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Platforms Rush to Establish Content-Authenticity Standards Amid Leadership Shakeups and Sustained Capex
Within days of each other in mid-August 2026, Google, Anthropic, and Spotify moved to formalize AI content watermarking and labeling policies, signaling an industry-wide push toward self-governed provenance standards as generative AI output floods consumer platforms. The shift coincides with executive turnover at OpenAI (Brad Lightcap's departure) and Meta's public AI manifesto, all set against continued heavy AI infrastructure capital expenditure and finance-sector moves (e.g., Wall Street paying for algorithmic edges on social signals) that underscore AI's deepening entanglement with capital markets.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts report JPMorgan Chase & Co.'s revenue for the same fiscal period (FY 2025) with the same observation date (2025-12-31), but with different values: $182.447 billion vs. $185 billion. The ~1.4% difference ($2.553 billion) is too large to be explained by rounding alone and represents conflicting data for the identical time period.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,977
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,977 facts checked against source5,242 source documents archived
Work with this data → vianewsagency.com
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· February 12, 2026

Orion-konsernin tilinpäätöstiedote tammi–joulukuu 2025

View original at globenewswire.com
Orion-konsernin tilinpäätöstiedote tammi–joulukuu 2025 ORION OYJ TILINPÄÄTÖSTIEDOTE 1–12/2025 12.2.2026 klo 12:00 Orion-konsernin tilinpäätöstiedote tammi–joulukuu 2025 Loka–joulukuu 2025 lyhyesti Liikevaihto oli 695,3 miljoonaa euroa (434,4 miljoonaa euroa 10–12/2024)Liikevoitto oli 328,1 (92,7) miljoonaa euroaLaiment…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • 2026 revenue expected to be 1,900-2,100 million EUR

    80% confidence

  • Nubeqa has repeatedly exceeded expectations

    80% confidence

  • Orion's performance was very strong in 2025 with solid financial results and clear progress in strategy implementation

    80% confidence

  • Generics and Consumer Health sales expected to be at same level or slightly higher than 2025

    80% confidence

  • No material change expected in total investment volume in 2026 compared to 2025

    80% confidence

  • Sales and marketing expenses expected to increase in 2026

    80% confidence

  • Orion's booked annual Nubeqa sales have potential to exceed 1 billion EUR by end of current decade

    80% confidence

  • Animal Health business unit expected to grow slightly in 2026

    80% confidence

  • Q4 2025 was a strong quarter that was a great ending to successful year 2025

    80% confidence

  • ODM-212 and its mechanism of action have significant potential in different indications

    80% confidence

  • Expects another very strong year in 2026 with continued work building wellbeing and Orion's future

    80% confidence

  • Company aims to expand ODM-212 phase 2 program during 2026

    80% confidence

  • Orion's booked Nubeqa royalties and product sales expected to grow significantly in 2026

    80% confidence

  • Branded Products business unit expected to grow in 2026 with respiratory diseases therapy area and Easyhaler portfolio as growth drivers

    80% confidence

  • 2026 operating profit expected to be 550-750 million EUR

    80% confidence

  • R&D expenses expected to increase in 2026 compared to 2025

    80% confidence

Cited in these Via News reports